Status
Conditions
Treatments
About
The purpose of the study is to assess the efficacy of vaginal micronized progesterone in the treatment of threatened miscarriage. All eligible pregnant women will be randomized to either receive vaginal progesterone or no treatment.Evaluation will be two weeks after intervention, then every 4 weeks up to 28 weeks gestation or termination of pregnancy.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
290 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Omar M Shaaban, MD; Hany Abdel-aleem, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal